Skip to main content

Advertisement

Table 1 Pre- and post-treatment larval faecal shedding of cats included in the study to evaluate the efficacy of Advocate® in the treatment of natural troglostrongylosis

From: Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate®) for the treatment of Troglostrongylus brevior in naturally infected cats in a field study in Greece

Study day Group n Mean LPG SD SE 95% CI Min-Max ANOVA
0 G1 8 31.88 36.247 12.815 1.57–62.18 15–120 F = 0.468; P = 0.505
G2 8 46.88 50.351 17.802 4.78–88.97 15–165
28 G1 8 20.63 7.763 2.745 14.13–27.12 15–30 F = 56.467; P < 0.001*
G2 8 0 0 0 0 0
56 G1 8 18.75 6.944 2.455 12.94–24.56 15–30 F = 58.333; P < 0.001*
G2 8 0 0 0 0 0
  1. Abbreviations: G1, cats treated with Advocate on study days 56/57 and 83/84; G2, cats treated with Advocate on study days 0 and 28/29; n, number of animals included in G1 or G2; LPG, larvae per gram; CI, confidence interval; SD, standard deviation; SE, standard error; Min, minimum; Max, maximum
  2. *Statistically significant results